Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis

IntroductionHyaluronidases (HAases) are enzymes related to cancer progression. Isoforms of HAases have been described as products of alternative splicing responsible for differences in enzyme activity. The heterogeneity of HAase expression has been identified in tumors and could be related to the differences in their biological behavior.MethodsThirty-seven patients subjected to radical prostatectomy for prostate cancer were divided into 2 groups for the analyses: Low (≤6–18) and high (≥7–19) Gleason score and tumor behavior; recurrence 15 and nonrecurrence 22, mean follow-up 52.6 months.ConclusionA profile of HAase related to low Gleason score and non-tumor recurrence was characterized by expression of HYAL3-v1, HYAL1-v3, and HYAL3-v2. More studies should be made in order to confirm with larger series.